Iceland· IS-EU/1/06/357/003-008 & 019-021

Gardasil

A humaner papillomvirus (typen 6, 11, 16, 18) product, registered in Iceland by Merck Sharp & Dohme B.V.*. The same ATC class is registered in 8 of our 19 countries.

ATC J07BM01

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedGardasilATCJ07BM01REGISTER NO.IS-EU/1/06/357/003-00…PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Humaner papillomvirus (typen 6, 11, 16, 18) is registered in 8 of 19 countries.

Countries holding a registration under ATC J07BM01 (humaner papillomvirus (typen 6, 11, 16, 18)), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 5 of them publish a price we can compare per daily dose

Humaner papillomvirus (typen 6, 11, 16, 18) · ATC J07BM01

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Manufacturer
Merck Sharp & Dohme B.V.*
Country
Iceland (IS)
ATC code
J07BM01
ATC class
Humaner Papillomvirus (Typen 6, 11, 16, 18)
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b5022923-429d-42f9-bb1d-6dd0b2ba34fd
GET /v1/drugs/b5022923-429d-42f9-bb1d-6dd0b2ba34fd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stungulyf, dreifa í áfylltri sprautu",
  "source": "lyfjastofnun",
  "atc_raw": "J07BM01",
  "marketed": false,
  "strength": null,
  "ma_number": "EU/1/06/357/003-008 & 019-021",
  "substance": "HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA,HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA,HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA,HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "39007"
}

See everything about humaner papillomvirus (typen 6, 11, 16, 18).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.